4//SEC Filing
MULLEN JAMES C 4
Accession 0001179110-22-000112
CIK 0001650664other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 4:23 PM ET
Size
4.8 KB
Accession
0001179110-22-000112
Insider Transaction Report
Form 4
MULLEN JAMES C
Director
Transactions
- Sale
Common Stock
2022-01-03$26.95/sh−18,252$491,979→ 75,898 total
Footnotes (1)
- [F1]Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on March 4, 2021, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on December 22, 2021. The sale does not represent a discretionary trade by the Reporting Person.
Documents
Issuer
Editas Medicine, Inc.
CIK 0001650664
Entity typeother
IncorporatedMA
Related Parties
1- filerCIK 0001226288
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 4:23 PM ET
- Size
- 4.8 KB